One year on from when lockdowns began in the west, specialists reflect on how these two fields have responded to the crisis.
Academic rigor, journalistic flair
Articles on COVID-19
Displaying 3241 - 3260 of 7973 articles
Real-world studies of vaccines aren’t directly comparable with clinical trials, but their results are still good news.
South Africa is aiming for 67% coverage, which translates to about 40 million people by the end of 2021.
Most of us don’t know yet when or where we’ll receive our COVID vaccination. But particularly as there’s a risk of scams, it’s important to be clear on how this process will (and won’t) play out.
As the one-year anniversary of the World Health Organization’s declaration of a pandemic approaches, it might be time to consider how our modern age wants to remember this plague.
Digital health can improve care, but in Ontario, health data are still fragmented, despite billions of dollars spent over the last two decades to enable fast and secure exchange of health information.
What does the coronavirus look like? What kids want to know about the pandemic isn’t always what we tell them.
In a digital age, and with unequal access to vaccines, there are considerable potential downsides to so-called ‘vaccine passports’.
According to a study conducted in collaboration with the Nobel laureate in economics, Lars Peter Hansen, decision theory is an effective tool for finding the best trade-offs.
There will be lessons we can learn for the future of childbearing once the pandemic is over.
Where there are not enough health workers to deliver medical care, one solution is to move certain tasks to less specialised health workers, a process called task-shifting.
An average healer in the rural South African town where the study was done experiences about 1,500 occupational blood exposures in their lifetime.
TV programmes with certain themes can help boost our mood.
Rashes and lesions are a potentially useful way of spotting COVID-19 patients who are otherwise asymptomatic.
A hospice doctor spent 10 years studying the end-of-life experiences of over 1,400 terminally ill patients.
A year after it became clear that COVID-19 was becoming a pandemic, there is still no cure, but doctors have several innovative treatments. Some are keeping patients out of the hospital entirely.
Perhaps we should rethink how we monitor pregnant women who have COVID.
Reluctance to take the vaccine may not be as unique to Black and Asian communities as it seems
B1525 is a new coronavirus variant under investigation by Public Health England.
Our new research found gaps in COVID information available to culturally and linguistically diverse communities. But there are ways we can improve — because community ownership is crucial.
Top contributors
-
Professorial Fellow, University of Canberra
-
Associate Professor, Epidemiology, Deakin University
-
Professor of Economics, UNSW Sydney
-
Chair in Epidemiology, Deakin University
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
-
Professor of Biostatistics and Epidemiology, University of South Australia
-
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Visiting Fellow, Crawford School of Public Policy, Australian National University
-
Senior Research Fellow in Global Health, University of Southampton
-
Professor of Medicine, University of East Anglia
-
Associate Professor, School of Population Health, UNSW Sydney
-
Professor of Medicine, University of Virginia
-
Professor of Public Health, University of Sheffield
-
Associate Professor of Bioethics, University of Portsmouth
